Read More Pharma Industry News Whitehawk Therapeutics (Nasdaq: WHWK) stock focus sharpens as ASCO 2026 data support SEZ6 ADC strategy in small cell lung cancer Find out how Whitehawk Therapeutics’ SEZ6 data at ASCO 2026 could shape its HWK-206 ADC strategy in small cell lung cancer. bySrinathMay 31, 2026